Skip to content

Alto Neuroscience ANRO Return on assets

Return on assets at other companies

Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-36%+8.4pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
27.4%+4.4pp
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-26.8%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-33.7%-10.0pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-69%
LBR
LB Pharmaceuticals Inc Common StockLBRX
-14.5%

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$874.19M+1,335%
Enterprise value$630.81M-940%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Calculated from Alto Neuroscience’s reported figures.

Based on trailing twelve months.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's return on assets?
Alto Neuroscience (ANRO) reported return on assets of -33.2% in Q1 2026.
How has Alto Neuroscience's return on assets changed year-over-year?
Alto Neuroscience's return on assets decreased by 0.2% year-over-year, from -33.1% to -33.2%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.